Bryan Faust, PhD
Investment Partner at Andreessen Horowitz Bio + Health
San Francisco, California
Summary
Bryan Faust is an Investment Partner on the Bio + Health team at Andreessen Horowitz (a16z), focusing on life science investment opportunities. He brings a deep scientific background to venture capital, identifying and supporting innovative biotechnologies. a16z+1
With a PhD in Biophysics from the University of California, San Francisco (UCSF), Bryan has extensive research experience in protein chemistry and antibody biophysics. His doctoral work explored antibody manipulation of protein conformation and G protein-coupled receptor activity. orcid+2
Bryan's scientific contributions include publications in leading journals such as Nature, Science, and Cell. Notably, he was a key researcher in the development of AeroNabs, a synthetic nanobody-based inhalable antiviral treatment for COVID-19, during his time at UCSF. a16z+2
Prior to his venture capital career, Bryan held R&D roles at major biopharmaceutical companies, including Scientist at AbbVie and Research Associate at Stemcentrx, Inc. and Genentech, where he specialized in protein chemistry and antibody biophysics. orcid+1
Beyond his professional pursuits, Bryan enjoys recreational activities such as surfing, roasting coffee, and seeking out the best tacos al pastor. a16z